ARTICLE | Company News
Dura, Spiros deal
February 22, 2000 8:00 AM UTC
DURA offered to reacquire its R&D arm, SDCO, for $12.50 per share, or about $79 million. If DURA buys SDCO, which it spun out in 1997, DURA will discontinue the Albuterol Spiros steroid program to tre...